0000899243-22-037467.txt : 20221202 0000899243-22-037467.hdr.sgml : 20221202 20221202173229 ACCESSION NUMBER: 0000899243-22-037467 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221130 FILED AS OF DATE: 20221202 DATE AS OF CHANGE: 20221202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Subramaniam Somu CENTRAL INDEX KEY: 0001508910 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40928 FILM NUMBER: 221443141 MAIL ADDRESS: STREET 1: C/O ICAD INC STREET 2: 98 SPIT BROOK ROAD SUITE 100 CITY: NASHUA STATE: NH ZIP: 03062 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ventyx Biosciences, Inc. CENTRAL INDEX KEY: 0001851194 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 832996852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 662 ENCINITAS BLVD., STE. 250 CITY: ENCINITAS STATE: CA ZIP: 92024 BUSINESS PHONE: (858) 945-2393 MAIL ADDRESS: STREET 1: 662 ENCINITAS BLVD., STE. 250 CITY: ENCINITAS STATE: CA ZIP: 92024 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-11-30 0 0001851194 Ventyx Biosciences, Inc. VTYX 0001508910 Subramaniam Somu C/O VENTYX BIOSCIENCES, INC. 662 ENCINITAS BLVD, SUITE 250 ENCINITAS CA 92024 1 0 1 0 Common Stock 2022-11-30 4 S 0 143228 29.0148 D 16745365 I See Footnotes Common Stock 2022-12-01 4 S 0 129317 29.0074 D 16616048 I See Footnotes Represents the weighted average share price of an aggregate total of 143,228 shares sold in the price range of $29.00 to $29.17. The reporting owner undertakes to provide upon request by the Securities and Exchange Commission ("Commission") staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Consists of (i) 5,873,225 shares held by NSV Investments I, LP, (ii) 2,295,172 shares held by NSV Master Limited Partnership II, LP, (iii) 2,005,725 shares held by NSV 2019 Opportunities Fund, LP, (iv) 1,731,080 shares held by NSV 2018 New Horizons Fund, LP, (v) 1,323,264 shares held by Life & Tech, (vi) 1,179,921 shares held by NSV Investments III, LP, (vii) 998,099 shares held by NSV Investments II, LP, (viii) 434,423 shares held by New Science Ventures, LLC, (ix) 270,682 shares held by NSV Growth Opportunities Fund, LP, (x) 185,779 shares held by New Science Ventures Fund III, LP, (xi) 163,286 shares held by NSV 2017 Opportunities Fund, LP, (xii) 113,862 shares held by NSV 2018 Opportunities Fund, LP, (xiii) 88,065 shares held by NSV 2016 Opportunities Fund, LP, (xiv) 58,565 shares held by New Science Ventures Fund III (Offshore), LP, and (xv) 24,217 shares held by NSV 2016 Opportunities Fund (Offshore), LP, collectively the NSV funds. NSV Partners III, LP, is the general partner of NSV 2018 New Horizons Fund LP, NSV Investments I, LP, NSV 2018 Opportunities Fund, LP, NSV 2019 Opportunities Fund, LP, NSV Growth Opportunities Fund, LP, NSV Investments III, LP, and NSV Investments II, LP. NSV Partners II, LLC, is the general partner of New Science Ventures Fund III, LP, New Science Ventures Fund III (Offshore), LP, NSV 2016 Opportunities Fund, LP, NSV 2016 Opportunities Fund (Offshore), LP, NSV 2017 Opportunities Fund, LP, and NSV Master Limited Partnership II, LP. The Reporting Person is the majority member and managing member of NSV Partners III GP, LLC, and may be deemed to have voting and dispositive power over the shares held by each entity of which NSV Partners III, LP is general partner. The Reporting Person disclaims beneficial ownership over the shares held by each of the NSV funds, except to the extent of his pecuniary interest therein. The Reporting Person is the majority member and managing member NSV Partners II, LLC, and may be deemed to have voting and dispositive power over the shares held by each entity of which NSV Partners II, LLC is general partner. Represents the weighted average share price of an aggregate total of 129,317 shares sold in the price range of $29.00 to $29.54. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Consists of (i) 5,873,225 shares held by NSV Investments I, LP, (ii) 2,295,172 shares held by NSV Master Limited Partnership II, LP, (iii) 1,990,010 shares held by NSV 2019 Opportunities Fund, LP, (iv) 1,704,590 shares held by NSV 2018 New Horizons Fund, LP, (v) 1,323,264 shares held by Life & Tech, (vi) 1,179,921 shares held by NSV Investments III, LP, (vii) 998,099 shares held by NSV Investments II, LP, (viii) 434,423 shares held by New Science Ventures, LLC, (ix) 269,055 shares held by NSV Growth Opportunities Fund, LP, (x) 160,722 shares held by New Science Ventures Fund III, LP, (xi) 141,262 shares held by NSV 2017 Opportunities Fund, LP, (xii) 98,504 shares held by NSV 2018 Opportunities Fund, LP, (xiii) 76,186 shares held by NSV 2016 Opportunities Fund, LP, (xiv) 50,665 shares held by New Science Ventures Fund III (Offshore), LP, and (xv) 20,950 shares held by NSV 2016 Opportunities Fund (Offshore), LP, collectively the NSV funds. /s/ Christopher Krueger, as Attorney-in-Fact 2022-12-02